Phaos Technology Holdings (Cayman) (POAS) Debt Ratio (2024 - 2025)

Phaos Technology Holdings (Cayman)'s (POAS) quarterly Debt Ratio came in at 0.08 in Q4 2025, up 20.28% on a QoQ basis from 0.07 in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Debt Ratio (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman) (POAS) has 2 years of Debt Ratio data on file, last reported at 0.08 in Q4 2025.

Quarterly Debt Ratio changed N/A year-over-year to 0.08 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was 0.08 (changed N/A YoY) and the FY2025 annual result came in at 0.07, down 37.48% from the prior year.
Debt Ratio improved to 0.08 in Q4 2025, from 0.07 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 0.11 in Q2 2024 to a low of 0.07 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	0.30
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	0.31
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	0.30
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	0.28
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	0.04
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	0.27
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	0.28
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	0.18
10	Phaos Technology Holdings (Cayman)	4.24 Mn	4.20 Mn	-	0.08

Download Data